IMPORTANT NOTICE:
The ISDB-website has had several hack attempts. If you receive an email that appears to come from Dick Bijl or any other member of the ISDB committee asking for money, please delete the email or report it as spam to your email provider. Recently, new attempts were initiated.
Unknown people steal identities from the ISDB Committe (identity fraud), sometimes they use spoofing.
Note that ISDB never asks members to contribute financially apart from their usual subscriptions.
News on Covid-19
ISDB informs you about the pro’s and con’s of drugs and drug treatments related to the current SARS-CoV-19 pandemic.
As far as possible we will inform you in different languages.
- Rational pharmacotherapy in times of pandemic
- THE HOME TREATMENT OF THE COVID-19 PATIENT
- Update: Remdesivir as a potential therapy against COVID-19
- Remdesivir as a potential therapy against COVID-19
- Chloroquine and hydroxychloroquine as potential therapies against COVID-19
- Remdesivir as a potential therapy against COVID-19
- Medications Compromising Covid Infections [EN]
- Statement: COVID-19 [EN]
- Consideraciones para minimizar los riesgos de complicaciones cardíacas si se decide la administración de cloroquina o hidroxicloroquina a pacientes hospitalizados con Covid-19
- Cloroquina e hidroxicloroquina no han demostrado ser eficaces en el tratamiento de pacientes con Covid-19
- Medicamentos y riesgo de neumonía [ES]
- Declaracion: COVID-19 [ES]